Cargando…

Real-Life Results of Palliative Chemotherapy in Metastatic Pancreatic Ductal Adenocarcinoma

SIMPLE SUMMARY: The available chemotherapeutic regimens for metastatic pancreatic ductal adenocarcinoma (mPDAC) in Romania include FOLFIRINOX (FFX), gemcitabine-based regimens (GB), and gemcitabine monotherapy (Gem). The purpose of our study was to compare the efficacy of FFX, GB, and Gem in patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Varzaru, Bianca, Iacob, Razvan A., Croitoru, Adina E., Iacob, Speranta M., Radu, Cristina E., Dumitrescu, Stefania M., Gheorghe, Cristian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340738/ https://www.ncbi.nlm.nih.gov/pubmed/37444612 http://dx.doi.org/10.3390/cancers15133500

Ejemplares similares

Endoscopic ultrasound-guided fine-needle aspiration pancreatic adenocarcinoma samples yield adequate DNA for next-generation sequencing: A cohort analysis
por: Bunduc, Stefania, et al.
Publicado: (2023)

Liquid Biopsy in Squamous Cell Carcinoma of the Esophagus and of the Head and Neck
por: Iacob, Razvan, et al.
Publicado: (2022)

Genetic and Life Style Risk Factors for Recurrent Non-alcoholic Fatty Liver Disease Following Liver Transplantation
por: Iacob, Speranta, et al.
Publicado: (2022)

Cholangiocellular carcinoma occurrence after HCV eradication therapy: case series and review of the literature
por: Cerban, Razvan, et al.
Publicado: (2022)

Liquid biopsy for early detection of hepatocellular carcinoma
por: Manea, Ioana, et al.
Publicado: (2023)

Assessment of Sarcopenia Related Quality of Life Using SarQoL® Questionnaire in Patients With Liver Cirrhosis
por: Iacob, Speranta, et al.
Publicado: (2022)

Pre and post-liver transplant outcome of cirrhotic patients with acute on chronic liver failure
por: Iacob, Speranta, et al.
Publicado: (2020)

Complete Radiologic Response of Metastatic Pancreatic Ductal Adenocarcinoma to Microwave Ablation Combined with Second-Line Palliative Chemotherapy
por: Blomstrand, Hakon, et al.
Publicado: (2020)

Editorial: Sarcopenia, Frailty and Nutrition in Liver Diseases
por: Iacob, Speranta, et al.
Publicado: (2022)

Host and immunosuppression-related factors influencing fibrosis occurrence post liver transplantation
por: Iacob, Speranta, et al.
Publicado: (2022)

Metastatic neuroendocrine pancreatic tumor – Case report
por: Radu, EC, et al.
Publicado: (2018)

The survival impact of palliative radiotherapy on synchronous metastatic pancreatic ductal adenocarcinoma: metastatic site can serve for radiotherapy-decision
por: Xu, Biaoxiang, et al.
Publicado: (2022)

Plasma Small Extracellular Vesicles Derived miR-21-5p and miR-92a-3p as Potential Biomarkers for Hepatocellular Carcinoma Screening
por: Sorop, Andrei, et al.
Publicado: (2020)

Pancreatic ductal adenocarcinoma in colonic wall: metastatic disease or cancerized pancreatic ectopic tissue?
por: Gallo, Graziana, et al.
Publicado: (2020)

Association of Antibiotic Receipt With Survival Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma Receiving Chemotherapy
por: Fulop, Daniel J., et al.
Publicado: (2023)

The hepatic pre-metastatic niche in pancreatic ductal adenocarcinoma
por: Houg, Demi S., et al.
Publicado: (2018)

Applied precision medicine in metastatic pancreatic ductal adenocarcinoma
por: Taghizadeh, Hossein, et al.
Publicado: (2020)

Pancreatic ductal adenocarcinoma: Role of chemotherapy & future perspectives
por: Tiwari, Akash, et al.
Publicado: (2018)

Estimating Metastatic Risk of Pancreatic Ductal Adenocarcinoma at Single-Cell Resolution
por: Chen, Sina, et al.
Publicado: (2022)

Molecular and metabolic regulation of immunosuppression in metastatic pancreatic ductal adenocarcinoma
por: Gautam, Shailendra K., et al.
Publicado: (2023)

Syndecans and Pancreatic Ductal Adenocarcinoma
por: Betriu, Nausika, et al.
Publicado: (2021)

Comparison of FOLFIRINOX vs Gemcitabine Plus Nab-Paclitaxel as First-Line Chemotherapy for Metastatic Pancreatic Ductal Adenocarcinoma
por: Klein-Brill, Avital, et al.
Publicado: (2022)

Neovascular Prostate-Specific Membrane Antigen Expression Is Associated with Improved Overall Survival under Palliative Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma
por: Stock, Katharina, et al.
Publicado: (2017)

A Survival Model in Locally Advanced and Metastatic Pancreatic Ductal Adenocarcinoma
por: Wang, Yi, et al.
Publicado: (2018)

Switchable CAR-T cells mediate remission in metastatic pancreatic ductal adenocarcinoma
por: Raj, Deepak, et al.
Publicado: (2019)

Gene expression profiling of pancreatic ductal adenocarcinomas in response to neoadjuvant chemotherapy
por: Sahni, Sumit, et al.
Publicado: (2023)

PTEN-Dependent Stabilization of MTSS1 Inhibits Metastatic Phenotype in Pancreatic Ductal Adenocarcinoma
por: Zeleniak, Ann E., et al.
Publicado: (2017)

Potential Circulating Biomarkers of Recurrence after Hepatic Resection or Liver Transplantation in Hepatocellular Carcinoma Patients
por: Duda, Dan G., et al.
Publicado: (2020)

Advances in Immunotherapeutics in Pancreatic Ductal Adenocarcinoma
por: Chouari, Tarak, et al.
Publicado: (2023)

Mimics of pancreatic ductal adenocarcinoma
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013)

Pancreatic ductal adenocarcinoma staging
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013)

Models of pancreatic ductal adenocarcinoma
por: Dennaoui, Rayane, et al.
Publicado: (2021)

Diagnostic Value of Artificial Intelligence-Assisted Endoscopic Ultrasound for Pancreatic Cancer: A Systematic Review and Meta-Analysis
por: Dumitrescu, Elena Adriana, et al.
Publicado: (2022)

Divergent Roles of Mitochondria Dynamics in Pancreatic Ductal Adenocarcinoma
por: Carmona-Carmona, Cristian Andres, et al.
Publicado: (2022)

CD95 promotes metastatic spread via Sck in pancreatic ductal adenocarcinoma
por: Teodorczyk, M, et al.
Publicado: (2015)

Clinical Outcomes Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma Treated With Liposomal Irinotecan
por: Yu, Kenneth H., et al.
Publicado: (2021)

THBS2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinoma
por: Gimotty, Phyllis A., et al.
Publicado: (2021)

LUNG ULTRASOUND IN NEONATES WITH COVID-19 PNEUMONIA – THE START OF A NEW ERA
por: Stoicescu, Emil - Robert, et al.
Publicado: (2022)

Immunobiological effects of gemcitabine and capecitabine combination chemotherapy in advanced pancreatic ductal adenocarcinoma
por: Middleton, Gary, et al.
Publicado: (2016)

Incidence and frequency of cancer cachexia during chemotherapy for advanced pancreatic ductal adenocarcinoma
por: Mitsunaga, Shuichi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bagnlvruhifqin394ifkt23uto